Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage

NCT07208097 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07208097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07208097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 25, 2025
Completion date
June 30, 2028
Enrollment
768 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral haemorrhage, minimally invasive treatment